Provided by Tiger Fintech (Singapore) Pte. Ltd.

Entasis Therapeutics Holdings Inc.

2.19
+0.0000
Volume:- -
Turnover:142.76K
Market Cap:104.80M
PE:-1.95
High:2.19
Open:2.19
Low:2.19
Close:2.19
Loading ...
May 07, 2020

Major Issues Report

Current report, items 2.02 and 9.01
May 01, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 29, 2020

Major Issues Report

Current report, item 5.02
Apr 23, 2020

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Apr 22, 2020

Major Issues Report

8-K - Current report
Apr 13, 2020

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
Mar 23, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 11, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 13, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jan 13, 2020

Major Issues Report

Current report, item 5.02
Nov 14, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 21, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Oct 15, 2019

Correspondence

[Cover]Correspondence
Aug 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 06, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 06, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities